Epidermolysis Bullosa (EB)
We are developing the topical therapy SD-101 for the treatment of skin blistering and lesions associated with Epidermolysis Bullosa (EB).
- EB is a rare, genetic disorder that manifests as blistering or erosion of the skin, and, in some cases, the epithelial lining of other organs.
- EB is chronic, potentially disfiguring, and in some cases fatal. Patients with EB have painful wounds and blisters that can lead to infection and scarring.
- There are many genetic and symptomatic variations of EB, but all forms share the common symptom of fragile skin that blisters and tears, sometimes from the slightest friction or trauma.
- There is currently no approved treatment for EB. Current standard of care consists of pain management and the bandaging and cleaning of open wounds to prevent infection.
For more information about Epidermolysis Bullosa (EB), download our Epidermolysis Bullosa infographic.